Technology

Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.

Califf Seeks Evidence to Guide Regulatory Decisions

ByJill Wechsler, Pharm Exec’s Washington Correspondent

May 15th 2016

May 16, 2016.

Takeda Receives Grant from Bill & Melinda Gates Foundation

May 13th 2016

May 13, 2016.

Technology

Latest News

FDA Reiterates Decision on Suffixes in Biosimilar Naming

Global Market for Wearable Medical Devices Could Reach $24 Billion in 2016

Shire to Create Up to 200 Jobs at Baxalta Facility

Pharma Failing to Address Corruption Risks, Says Report

Dutch System to Track Biosimilar Use and Switching Announced

Jazz Pharmaceuticals Acquires Celator

Governments on Track to Eliminate Viral Hepatitis by 2030

EMA to Review Safety in First-in-Human Clinical Trials

Valeant Rejected Takeda Bid

Gilead Brings Top Exec Out of Retirement

EFPIA: TTIP Must Go Further to Tackle Regulatory Barriers

Lilly Says Company Could Launch 20 Products in 10 Years

Sanofi Loses Three Top Execs in Reshuffle

EMA Publishes Annual Report

Third Sector "Ready" to Fight Antimicrobial Resistance

NIH to Launch Large-Scale HIV Vaccine Trial

Biopharma Supports Nearly 4.5 Million US Jobs, Says Report

Valeant Holds On to Top Execs with Million-Dollar Bonus Payouts

Pfizer to Acquire Anacor

UK Tops Europe for Regulatory Affairs Vacancies

Vote for Thomson Reuters' Top BioPharma Deals of the Year

Registries and the Future of Medicine

Califf Seeks Evidence to Guide Regulatory Decisions

Takeda Receives Grant from Bill & Melinda Gates Foundation

Opdivo Will Help Boost Non-Small Cell Lung Cancer Market in Asia-Pac

Trending on PharmExec

FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report

Everything to Know About TrumpRx in 2026

Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill

Pharmaceutical Executive Daily: The Launch of TrumpRx